M Rezaee, N Azizi, B Danaei, A Davari, S A Nejadghaderi, T Sarmastzadeh, M Rahmannia, F Khalili, A H Shahidi-Bonjar, R Centis, L D'Ambrosio, G Sotgiu, G B Migliori, M J Nasiri
{"title":"肺结核与间质性肺病:系统回顾与荟萃分析。","authors":"M Rezaee, N Azizi, B Danaei, A Davari, S A Nejadghaderi, T Sarmastzadeh, M Rahmannia, F Khalili, A H Shahidi-Bonjar, R Centis, L D'Ambrosio, G Sotgiu, G B Migliori, M J Nasiri","doi":"10.5588/ijtld.23.0428","DOIUrl":null,"url":null,"abstract":"<p><p><sec id=\"st1\"><title>INTRODUCTION</title>To determine the frequency of TB among patients with interstitial lung diseases (ILDs).</sec><sec id=\"st2\"><title>METHODS</title>We performed a comprehensive search in the PubMed/Medline, EMBASE and Scopus databases up to 1 August 2023 of studies reporting on the prevalence of TB among patients with ILDs.</sec><sec id=\"st3\"><title>RESULTS</title>Twelve studies comprising 3,817 patients with ILD were found: the pooled prevalence of TB among ILD patients was 11.0% (95% CI 5.4-21.0). In the subgroup analysis, the TB rate among patients with silicosis and idiopathic pulmonary fibrosis (IPF) was respectively 35.6% (95% CI 32.6-38.8) and 4.4% (95% CI 3.6-5.3) (<i>P</i> = 0.00). The frequency of TB among ILD patients was higher in high TB burden countries than in low/intermediate-burden countries: 26.3%, 95% CI 17.7-37.3 vs. 4.9%, 95% CI 3.3-7.2; <i>P</i> = 0.00.</sec><sec id=\"st4\"><title>CONCLUSIONS</title>This study shows the frequency of TB among ILD patients. The meta-analysis reveals a significantly increased prevalence of TB among ILD patients with silicosis compared to IPF, and among individuals in high TB burden countries than in those with low/intermediate burden. The study results can help physicians and policymakers make efficient decisions for prompt screening and anti-TB treatment initiation in ILD patients.</sec>.</p>","PeriodicalId":14411,"journal":{"name":"International Journal of Tuberculosis and Lung Disease","volume":"28 3","pages":"130-135"},"PeriodicalIF":3.4000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"TB and interstitial lung disease: a systematic review and meta-analysis.\",\"authors\":\"M Rezaee, N Azizi, B Danaei, A Davari, S A Nejadghaderi, T Sarmastzadeh, M Rahmannia, F Khalili, A H Shahidi-Bonjar, R Centis, L D'Ambrosio, G Sotgiu, G B Migliori, M J Nasiri\",\"doi\":\"10.5588/ijtld.23.0428\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><sec id=\\\"st1\\\"><title>INTRODUCTION</title>To determine the frequency of TB among patients with interstitial lung diseases (ILDs).</sec><sec id=\\\"st2\\\"><title>METHODS</title>We performed a comprehensive search in the PubMed/Medline, EMBASE and Scopus databases up to 1 August 2023 of studies reporting on the prevalence of TB among patients with ILDs.</sec><sec id=\\\"st3\\\"><title>RESULTS</title>Twelve studies comprising 3,817 patients with ILD were found: the pooled prevalence of TB among ILD patients was 11.0% (95% CI 5.4-21.0). In the subgroup analysis, the TB rate among patients with silicosis and idiopathic pulmonary fibrosis (IPF) was respectively 35.6% (95% CI 32.6-38.8) and 4.4% (95% CI 3.6-5.3) (<i>P</i> = 0.00). The frequency of TB among ILD patients was higher in high TB burden countries than in low/intermediate-burden countries: 26.3%, 95% CI 17.7-37.3 vs. 4.9%, 95% CI 3.3-7.2; <i>P</i> = 0.00.</sec><sec id=\\\"st4\\\"><title>CONCLUSIONS</title>This study shows the frequency of TB among ILD patients. The meta-analysis reveals a significantly increased prevalence of TB among ILD patients with silicosis compared to IPF, and among individuals in high TB burden countries than in those with low/intermediate burden. The study results can help physicians and policymakers make efficient decisions for prompt screening and anti-TB treatment initiation in ILD patients.</sec>.</p>\",\"PeriodicalId\":14411,\"journal\":{\"name\":\"International Journal of Tuberculosis and Lung Disease\",\"volume\":\"28 3\",\"pages\":\"130-135\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Tuberculosis and Lung Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.5588/ijtld.23.0428\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Tuberculosis and Lung Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5588/ijtld.23.0428","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
摘要
方法我们在PubMed/Medline、EMBASE和Scopus数据库中全面检索了截至2023年8月1日有关ILD患者肺结核发病率的研究报告。结果发现了12项研究,包括3817名ILD患者:ILD患者的肺结核总发病率为11.0%(95% CI为5.4-21.0)。在亚组分析中,矽肺和特发性肺纤维化 (IPF) 患者的结核病发病率分别为 35.6% (95% CI 32.6-38.8) 和 4.4% (95% CI 3.6-5.3) (P = 0.00)。肺结核在 ILD 患者中的发病率在结核病高负担国家高于低/中等负担国家:26.3%,95% CI 17.7-37.3 vs. 4.9%,95% CI 3.3-7.2; P = 0.00.结论本研究显示了肺结核在 ILD 患者中的发病率。荟萃分析表明,与 IPF 相比,患有矽肺的 ILD 患者中结核病的发病率明显增加,而且结核病高负担国家的结核病发病率明显高于低/中负担国家。研究结果有助于医生和决策者做出有效决策,对 ILD 患者进行及时筛查并开始抗结核治疗。
TB and interstitial lung disease: a systematic review and meta-analysis.
INTRODUCTIONTo determine the frequency of TB among patients with interstitial lung diseases (ILDs).METHODSWe performed a comprehensive search in the PubMed/Medline, EMBASE and Scopus databases up to 1 August 2023 of studies reporting on the prevalence of TB among patients with ILDs.RESULTSTwelve studies comprising 3,817 patients with ILD were found: the pooled prevalence of TB among ILD patients was 11.0% (95% CI 5.4-21.0). In the subgroup analysis, the TB rate among patients with silicosis and idiopathic pulmonary fibrosis (IPF) was respectively 35.6% (95% CI 32.6-38.8) and 4.4% (95% CI 3.6-5.3) (P = 0.00). The frequency of TB among ILD patients was higher in high TB burden countries than in low/intermediate-burden countries: 26.3%, 95% CI 17.7-37.3 vs. 4.9%, 95% CI 3.3-7.2; P = 0.00.CONCLUSIONSThis study shows the frequency of TB among ILD patients. The meta-analysis reveals a significantly increased prevalence of TB among ILD patients with silicosis compared to IPF, and among individuals in high TB burden countries than in those with low/intermediate burden. The study results can help physicians and policymakers make efficient decisions for prompt screening and anti-TB treatment initiation in ILD patients..
期刊介绍:
The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.